Company news
Regenerative Medical Technology Group Inc. news in 2026
Regenerative Medical Technology Group Inc.'s news releases, calls and decks from 2026, newest first.
RMTG's ISSCA Division Announces Successful Santa Cruz, Bolivia Conference, October 23-24
October 26, 2026
RMTG's ISSCA Division Returns to São Paulo for a Second Brazil Congress, November 20-21
October 22, 2026
RMTG to Go Ringside at BKFC This Weekend to Capture Content for Its "RMTG Brief" Investor-Awareness Campaign
October 20, 2026
RMTG's ISSCA Division Expands Global Online Academy With Ten New Curriculum Tracks
October 8, 2026
RMTG Broadens Longevity Footprint With New ISSCA Certification Across Adjunctive Therapies
October 5, 2026
RMTG Expands Peptide Education Platform With ISSCA Peptide Certification 2.0 and New Physician Reference Guides
October 1, 2026
RMTG's ISSCA Division to Host ISSCA 125 Global Summit in Cancún, Mexico
September 21, 2026
RMTG's ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI(TM) Strategy
September 17, 2026
Regenerative Medical Technology Group, Inc. Details Expanded ISSCA AI(TM) Clinical Intelligence Platform, Including Protocol-Native Engine, Structured Data Assets, and Multi-Line Commercial Model
September 14, 2026
RMTG's Cellgenic Division Begins Local Commercial Activity in Colombia, Subject to Colombian Regulatory Requirements
September 8, 2026
Cellgenic Establishes Local Commercial Presence in Brazil
September 3, 2026
RMTG's Cellgenic Commences Commercial Activity in Peru, Extending Its Latin American Footprint
September 1, 2026
RMTG's Cellgenic Division Introduces MUSE Cell Product Line Across Four International Regions
August 27, 2026
RMTG Acquires RMTG.com Domain and Launches New Investor-Focused Website, Advancing Shareholder Engagement
August 26, 2026
RMTG's Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets
August 24, 2026
RMTG More Than Quadruples Revenue and Gross Profit in Q2 2026 Versus Q2 2025, With Operating Income Surpassing $560,000
August 20, 2026
RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions
August 19, 2026
RMTG Expands Cellgenic's Cancún Laboratory Infrastructure with Two Additional ISO 7 Clean Rooms
August 18, 2026
RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
August 5, 2026
RMTG Expands Cellgenic Operations Into Argentina, Establishing a Strategic Commercial Hub for Regenerative Medicine in Latin America
July 23, 2026
RMTG Launches ISSCA AI(TM) Clinical Intelligence Platform, Extending Its Global Regenerative Medicine Network Into AI-Driven Clinical Infrastructure
June 23, 2026
Global Stem Cells Group (OTC: RMTG) Launches ISSCA Mobile App, Advancing Its Buildout of a Global Digital Ecosystem for Regenerative Medicine
June 17, 2026
RMTG Surges 93% in Revenue, 87% in Gross Profit and 70% in Operating Income for Q1 2026 vs Q1 2025
June 10, 2026
RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind
March 26, 2026